A detailed history of Plato Investment Management LTD transactions in Dexcom Inc stock. As of the latest transaction made, Plato Investment Management LTD holds 7,603 shares of DXCM stock, worth $608,544. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,603
Previous 13,405 43.28%
Holding current value
$608,544
Previous $1.52 Billion 66.5%
% of portfolio
0.04%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$64.0 - $116.06 $371,328 - $673,380
-5,802 Reduced 43.28%
7,603 $509 Million
Q2 2024

Aug 08, 2024

SELL
$110.31 - $140.45 $39,490 - $50,281
-358 Reduced 2.6%
13,405 $1.52 Billion
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $1.3 Million - $1.59 Million
11,346 Added 469.42%
13,763 $2.93 Billion
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $182,459 - $300,094
2,417 New
2,417 $300 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.